| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |